Cambridge, UK and Cambridge, Massachusetts – 17 April 2007 – Acambis plc (Acambis) (LSE: ACM) announces that the US Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (the Advisory Committee) will review Acambis’ ACAM2000 smallpox vaccine on 17 May 2007.
